12 research outputs found
Common variants in CLDN2 and MORC4 genes confer disease susceptibility in patients with chronic pancreatitis
A recent Genome-wide Association Study (GWAS) identified association with variants in X-linked CLDN2 and MORC4 and PRSS1-PRSS2 loci with Chronic Pancreatitis (CP) in North American patients of European ancestry. We selected 9 variants from the reported GWAS and replicated the association with CP in Indian patients by genotyping 1807 unrelated Indians of Indo-European ethnicity, including 519 patients with CP and 1288 controls. The etiology of CP was idiopathic in 83.62% and alcoholic in 16.38% of 519 patients. Our study confirmed a significant association of 2 variants in CLDN2 gene (rs4409525—OR 1.71, P = 1.38 x 10-09; rs12008279—OR 1.56, P = 1.53 x 10-04) and 2 variants in MORC4 gene (rs12688220—OR 1.72, P = 9.20 x 10-09; rs6622126—OR 1.75, P = 4.04x10-05) in Indian patients with CP. We also found significant association at PRSS1-PRSS2 locus (OR 0.60; P = 9.92 x 10-06) and SAMD12-TNFRSF11B (OR 0.49, 95% CI [0.31–0.78], P = 0.0027). A variant in the gene MORC4 (rs12688220) showed significant interaction with alcohol (OR for homozygous and heterozygous risk allele -14.62 and 1.51 respectively, P = 0.0068) suggesting gene-environment interaction. A combined analysis of the genes CLDN2 and MORC4 based on an effective risk allele score revealed a higher percentage of individuals homozygous for the risk allele in CP cases with 5.09 fold enhanced risk in individuals with 7 or more effective risk alleles compared with individuals with 3 or less risk alleles (P = 1.88 x 10-14). Genetic variants in CLDN2 and MORC4 genes were associated with CP in Indian patients
Pancreatic Head Mass in Chronic Pancreatitis is Inflammatory in Alcoholic Pancreatitis and Often Malignant in Idiopathic Chronic Pancreatitis
T1387 Idiopathic Chronic Pancreatitis, Diabetes, and Smoking are Significant Risk Factors for Pancreatic Cancer: Results of Case-Control and Cohort Studies
Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis.
A recent genome-wide association study (GWAS) identified association with variants in X-linked CLDN2 and MORC4, and PRSS1-PRSS2 loci with chronic pancreatitis (CP) in North American patients of European ancestry. We selected 9 variants from the reported GWAS and replicated the association with CP in Indian patients by genotyping 1807 unrelated Indians of Indo-European ethnicity, including 519 patients with CP and 1288 controls. The etiology of CP was idiopathic in 83.62% and alcoholic in 16.38% of 519 patients. Our study confirmed a significant association of 2 variants in CLDN2 gene (rs4409525-OR 1.71, P = 1.38 x 10-09; rs12008279-OR 1.56, P = 1.53 x 10-04) and 2 variants in MORC4 gene (rs12688220-OR 1.72, P = 9.20 x 10-09; rs6622126-OR 1.75, P = 4.04x10-05) in Indian patients with CP. We also found significant association at PRSS1-PRSS2 locus (OR 0.60; P = 9.92 x 10-06) and SAMD12-TNFRSF11B (OR 0.49, 95% CI [0.31-0.78], P = 0.0027). A variant in the gene MORC4 (rs12688220) showed significant interaction with alcohol (OR for homozygous and heterozygous risk allele -14.62 and 1.51 respectively, P = 0.0068) suggesting gene-environment interaction. A combined analysis of the genes CLDN2 and MORC4 based on an effective risk allele score revealed a higher percentage of individuals homozygous for the risk allele in CP cases with 5.09 fold enhanced risk in individuals with 7 or more effective risk alleles compared with individuals with 3 or less risk alleles (P = 1.88 x 10-14). Genetic variants in CLDN2 and MORC4 genes were associated with CP in Indian patients
Raw genotype information for samples for all studied SNPs
*Sex chromosomal SNP
For sex chromosomal SNP, genotype for male hemizygote has been coded as homozygote genotype for corresponding allele.
Sex (1=Male; 2=Female), Pheno (1=Case, 2=Control)
Combined risk analysis to determine the effect of increase in number of ‘effective’ risk alleles with risk of CP.
<p>On <i>y</i>-axis OR and 95% CI are plotted, corresponding to number of effective risk alleles on the <i>x</i>-axis. Number in parenthesis on the <i>x</i>-axis indicates Sample size in each category. For every unit increase in the number of effective’ risk allele, the OR is 1.20 and <i>P</i> value 7.30 x 10<sup>-08</sup>.</p
Demographic data of patients with ICP, ACP and controls used in the study.
<p>Demographic data of patients with ICP, ACP and controls used in the study.</p
Association of SNPs with CP in ICP cases (n = 434) and control (n = 1288) subjects.
<p>Association of SNPs with CP in ICP cases (n = 434) and control (n = 1288) subjects.</p
Association of SNPs with CP in ACP cases (n = 85) and control (n = 1288) subjects.
<p>Association of SNPs with CP in ACP cases (n = 85) and control (n = 1288) subjects.</p
Comparison of SNPs at <i>CLDN2</i> and <i>MORC4</i> locus in CP cases and controls.
<p>Comparison of SNPs at <i>CLDN2</i> and <i>MORC4</i> locus in CP cases and controls.</p